Herzog, T. J., Krivak, T. C., Bush, S., Diaz, J. P., Lentz, S., Nair, N., . . . Claudio, P. P. ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial. Nature Portfolio.
Chicago Style (17th ed.) CitationHerzog, Thomas J., et al. ChemoID-guided Therapy Improves Objective Response Rate in Recurrent Platinum-resistant Ovarian Cancer Randomized Clinical Trial. Nature Portfolio.
MLA (9th ed.) CitationHerzog, Thomas J., et al. ChemoID-guided Therapy Improves Objective Response Rate in Recurrent Platinum-resistant Ovarian Cancer Randomized Clinical Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.